Literature DB >> 8335170

Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve.

D W Zochodne1, L T Ho.   

Abstract

Loss of neurogenic inflammation in response to tissue injury may be an important complication of diabetes mellitus. We studied local neurogenic inflammation in the peripheral nerve trunk of Sprague-Dawley rats 4 months following the induction of diabetes by streptozotocin injection. To assess neurogenic inflammation, the epineurial plexus of the sciatic nerve was exposed to topical capsaicin, an agent that releases vasoactive neuropeptides from perivascular afferent terminals. Under normal circumstances, local vasodilation results in endoneurial hyperaemia or a 'flare'. We evaluated the influence of capsaicin in diabetic sciatic nerve by making serial measurements of endoneurial blood flow using microelectrodes sensitive to hydrogen clearance. After 4 months of hyperglycaemia (glucose > 16.0 mmol/l), diabetic animals had slowing of unmyelinated and myelinated sural sensory conduction velocity compared to citrate buffer injected controls. Baseline sciatic endoneurial blood flow was unaltered by diabetes, and was comparable to controls. There was an expected hyperaemic response of endoneurial blood flow to capsaicin in control rat sciatic endoneurium but no consistent 'flare' response in diabetic rats. Our findings indicate that there is loss of capsaicin-related neurogenic inflammation in the vasa nervorum of experimental diabetes. It is possible that a similar deficit following nerve injury could impair the milieu for axonal regeneration in diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335170     DOI: 10.1007/bf02743263

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Early arteriolar disturbances following streptozotocin-induced diabetes mellitus in adult mice.

Authors:  H G Bohlen; B A Niggl
Journal:  Microvasc Res       Date:  1980-07       Impact factor: 3.514

2.  Differential vulnerability of neuropeptides in nerves of the vasa nervorum to streptozotocin-induced diabetes.

Authors:  P Milner; O Appenzeller; C Qualls; G Burnstock
Journal:  Brain Res       Date:  1992-03-06       Impact factor: 3.252

3.  Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.

Authors:  G Pugliese; R G Tilton; A Speedy; K Chang; E Santarelli; M A Province; D Eades; W R Sherman; J R Williamson
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

4.  Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor.

Authors:  A R Ekström; D R Tomlinson
Journal:  J Neurol Sci       Date:  1989-11       Impact factor: 3.181

5.  Vascular responsiveness and serum biochemical parameters in alloxan diabetes mellitus.

Authors:  P D Turlapaty; G Lum; B M Altura
Journal:  Am J Physiol       Date:  1980-12

6.  The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy.

Authors:  D W Zochodne; L T Ho
Journal:  Can J Neurol Sci       Date:  1992-11       Impact factor: 2.104

7.  Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy.

Authors:  R H King; J G Llewelyn; P K Thomas; S G Gilbey; P J Watkins
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Jul-Aug       Impact factor: 8.090

8.  Ultrastructural and immunohistochemical characterization of autonomic neuropathy in genetically diabetic Chinese hamsters.

Authors:  R E Schmidt; D A Plurad; S B Plurad; B E Cogswell; A R Diani; K A Roth
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

9.  Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.

Authors:  T S Lee; K A Saltsman; H Ohashi; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat.

Authors:  M A Pfaffman; C R Ball; A Darby; R Hilman
Journal:  Am J Physiol       Date:  1982-04
View more
  1 in total

1.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.